国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2010年
7期
557-558
,共2页
柳兴明%杨文发%汪辉%杨斌%陈昊%卢道远
柳興明%楊文髮%汪輝%楊斌%陳昊%盧道遠
류흥명%양문발%왕휘%양빈%진호%로도원
内皮缩血管肽类%癌,移行细胞%免疫组织化学
內皮縮血管肽類%癌,移行細胞%免疫組織化學
내피축혈관태류%암,이행세포%면역조직화학
Endothelins%Carcinoma,transitional cell%Immunohistochemistry
目的探讨内皮素(ET)-1在尿路移行细胞癌(肾盂、输尿管、膀胱癌)患者中的表达及其临床意义.方法应用免疫组化SP法对30例尿路移行细胞癌及20例正常肾盂、输尿管、膀胱组织石蜡切片中ET-1的表达进行检测,结合临床资料进行分析.结果 ET-1在肿瘤组织中的表达阳性率为40.5%,明显高于正常组(P<0.05).ET-1表达与尿路移行细胞癌组织学分级、临床分期相关(P<0.05).结论 ET-1表达异常提示其可能参与尿路移行细胞癌的发生、发展与浸润,有望成为治疗人类尿路移行细胞癌的作用靶点.
目的探討內皮素(ET)-1在尿路移行細胞癌(腎盂、輸尿管、膀胱癌)患者中的錶達及其臨床意義.方法應用免疫組化SP法對30例尿路移行細胞癌及20例正常腎盂、輸尿管、膀胱組織石蠟切片中ET-1的錶達進行檢測,結閤臨床資料進行分析.結果 ET-1在腫瘤組織中的錶達暘性率為40.5%,明顯高于正常組(P<0.05).ET-1錶達與尿路移行細胞癌組織學分級、臨床分期相關(P<0.05).結論 ET-1錶達異常提示其可能參與尿路移行細胞癌的髮生、髮展與浸潤,有望成為治療人類尿路移行細胞癌的作用靶點.
목적탐토내피소(ET)-1재뇨로이행세포암(신우、수뇨관、방광암)환자중적표체급기림상의의.방법응용면역조화SP법대30례뇨로이행세포암급20례정상신우、수뇨관、방광조직석사절편중ET-1적표체진행검측,결합림상자료진행분석.결과 ET-1재종류조직중적표체양성솔위40.5%,명현고우정상조(P<0.05).ET-1표체여뇨로이행세포암조직학분급、림상분기상관(P<0.05).결론 ET-1표체이상제시기가능삼여뇨로이행세포암적발생、발전여침윤,유망성위치료인류뇨로이행세포암적작용파점.
Objective To investigate the expression and significance of endothelin-1 ET-1 in urothelial transitional cell carcinoma. Methods Immunohistochemistry was applied to detect ET-1 expression in 30 cases of urothelial transitional cell carcinoma and 20 cases of normal urothelial transitional cell samples, the results were analyzed in combination with clinical data. Results ET-1 expression in urothelial transitional cell carcinoma was 40.5%, which was significantly higher than that in normal urothelial transitional cell samples(P <0.05). ET-1 expression was correlated with grade and stage of urothelial transitional cell carcinoma (P <0.05). Conclusion The over expression of ET-1 in urothelial transitional cell carcinoma tissues correlates closely with cancer genesis progression and invasiveness, suggesting that ET-1 might be a biomarker and as a therapeutic target in human urothelial transitional cell carcinoma.